Procter & Gamble
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Procter & Gamble
NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers – “is recognized as a consumer-relevant category."
Brush “provides live coaching” through embedded iOSense Charger to guide time, pressure and coverage without needing to watch smartphone app. Firm also extending Oral-B iO lineup with lower-priced iO4 and iO5 brushes available nationwide in the US beginning later in 2022.
ParaPatch developed patch to commercialize a home remedy and was chosen from a record number of submissions in contest. It will receive $10,000 and opportunity to partner with P&G Ventures to continue development.
Heading into the J.P. Morgan Healthcare conference, pharmas have been focusing on discovery alliances. J&J’s deals look into novel tissue-targeted drugs, ionic liquid delivery technology and cancer vaccine R&D. Lilly teams with Entos on novel methods for delivering neurology drugs.
- OTC, Consumer